May Hill Capital’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.3M Buy
36,659
+371
+1% +$29.7K 0.58% 35
2025
Q4
$3.46M Sell
36,288
-145
-0.4% -$14.2K 0.93% 21
2025
Q3
$3.56M Sell
36,433
-24,240
-40% -$2.51M 1.04% 21
2025
Q2
$6.52M Buy
60,673
+52
+0.1% +$5.26K 2.15% 9
2025
Q1
$6.12M Sell
60,621
-68
-0.1% -$6.85K 2.31% 9
2024
Q4
$5.42M Buy
+60,689
New +$5.34M 2.1% 9

Other funds holding BSX

May Hill Capital's BSX Position: Q1 2026 in Review

May Hill Capital increased its Boston Scientific (BSX) stake by 1% in Q1 2026, buying an estimated $29.7K and bringing the position to 36,659 shares worth $2.3M. The position accounts for 0.58% of the portfolio, ranked #35.

May Hill Capital first reported a position in BSX in Q4 2024 and has held it in 6 quarters since. The position peaked at $6.52M in Q2 2025. 1,666 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

  • May Hill Capital held 36,659 shares of Boston Scientific worth $2.3M as of Q1 2026.
  • May Hill Capital bought 371 Boston Scientific shares in Q1 2026, an estimated $29.7K.
  • Boston Scientific made up 0.58% of May Hill Capital's portfolio in Q1 2026, its #35 holding.
  • May Hill Capital first reported a position in Boston Scientific in Q4 2024 and has held it in 6 quarters since.
  • May Hill Capital's Boston Scientific position peaked at $6.52M in Q2 2025.
  • 1,666 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on May Hill Capital's 13F filing for Q1 2026, filed 6 May 2026.